New Institute name honours the late Bryan Hudson

By Hudson Institute communications

Today, the MIMR-PHI Institute of Medical Research has been renamed ‘Hudson Institute of Medical Research’ to honour the late Professor Bryan Hudson.

MIMR-PHI Institute has been renamed ‘Hudson Institute of Medical Research’ to honour the late Professor Bryan Hudson.

Hudson Institute Director, Professor Bryan Williams says Professor Hudson was a world-class medical researcher, innovator and a visionary leader.

“As both a physician and a scientist, Professor Hudson’s legacy exemplifies the values of the Institute – excellence in cutting-edge research and ensuring its positive impact on the health of the community,” he said.

The MIMR-PHI Institute came about as the result of a 2014 merger between two of Melbourne’s most trusted names in medical research, Monash Institute of Medical Research (MIMR) and Prince Henry’s Institute (PHI).

Now, with a combined 75 years of research experience, more than 450 leading researchers and postgraduate students, an annual budget of more than $45m, and state-of-the-art research facilities, the merged Institute has taken its place as a leader in medical research and its translation into the clinic.

“The diversity of our research is our strength. Our multidisciplinary research environment fosters collaboration and creates opportunities for unique insights and innovation to improve health and prevent and treat diseases across the entire lifespan,” said Professor Williams.

The Institute’s new name recognises the shared histories of its two founding partners.

“Professor Hudson was instrumental to the early origins of both MIMR and PHI. He was the first Professor of Medicine at Monash University and the Founding Chair of the University’s Department of Medicine. He was also the Founding Director of Prince Henry’s Institute (then called Prince Henry’s Hospital Medical Research Centre),” said Professor Williams.

Professor Hudson’s daughter, Leigh Bowring, is delighted that her father’s contribution to medicine and science is being recognised in this way.

“It is an honour for our family to know that my father’s legacy will live on through the Institute’s outstanding research. We look forward to seeing ground-breaking discoveries come out of the ‘Hudson Institute’,” said Mrs Bowring.

The new name comes at a crucial stage for the Institute, as it looks to open a new, $84 million, state-of-the-art Translational Research Facility, with its Monash Health Translation Precinct partners, Monash Health and Monash University, in September this year.

“The Translational Research Facility will transform the Institute’s research capability, allowing our researchers to make a far greater impact on health by driving their discoveries directly towards the clinic.

“The co-location of medical physicians and researchers in the facility will allow our researchers to effectively leverage the practical knowledge of their clinical colleagues to focus their research and ensure the most pressing diseases are being investigated,” said Professor Williams.

“This was Professor Hudson’s vision for translational research and, thanks to pioneers like him, the Institute is now in a position to take this vision to a new level and make a lasting impact on the quality of life of the community”.

Contact us

Hudson Institute communications
t: +61 3 8572 2697

About Hudson Institute

Hudson Institute’ s research programs deliver in five areas of medical need – inflammation, cancer, reproductive health, newborn health, and hormones and health. More

Hudson News

Get the inside view on discoveries and patient stories

“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”

Alana Chantry